
GeneDx @ ASHG 2025. Visit us at Booth #1146.
Learn how we are coming together to deliver clinical actionable genomic insights worldwide – enabling decentralized testing powered by centralized intelligence.
Thursday, October 16, 5:30-8:30 pm
Legal Sea Foods: 270 Northern Ave, Boston MA
Poster presentations will be held from October 15th-17th in the exhibit hall.
The clinical impact of a framework for validating gene-disease associations in a high-throughput clinical laboratory
Poster #: TBD
Maria Guillen Sacoto, MD, FACMG, Scientific Director, Research and Innovation, GeneDx
Beyond panels: the superior diagnostic utility of exome/genome sequencing in hearing loss
Poster #: TBD
Bobbi McGivern, MS, LCGC, Clinical Program Manager, Clinical & Translational Research, GeneDx
Copy Number Variant Detection by Exome or Genome Sequencing Is Highly Concordant with Chromosomal Microarray
Poster #: TBD
Sarah Poll, PhD, Director, Clinical Data Science & Research, GeneDx
Concordance of results from Cas9-Targeted Sequencing and LR-WGS with Results from Validated Clinical Methods for the diagnosis of Repeat Expansion Disorders
Poster #: TBD
Jessica Noya, Senior Laboratory Scientist, GeneDx
Gene-based burden testing of rare variants identifies established and novel genetic contributors to Intellectual Disability
Poster #: TBD
Thorhildur Juliusdottir, Director, Statistical Genetics, GeneDx
A machine learning approach for identifying de novo variants with high accuracy in a high-throughput genomic testing laboratory
Poster #: TBD
Robert Kueffner, Machine Learning Engineer, GeneDx
Using GORdb to leverage large scale genotype and phenotype data to confirm and explore new gene disease associations
Poster #: TBD
Hakon Gudbjartsson, PhD, GeneDx
GUARDIAN Expanded NBS Study: Short- and Medium-Term Follow-Up with the First 15,000 Participants Enrolled
Presented by: Brenna Boyd, Columbia University Irving Medical Center

Thursday, October 16, 9:15–9:30am

Brenna Boyd, Columbia University Irving Medical Center
Shared and distinct genetic architectures of autism and neuropsychiatric disorders
Presented by: Jack Fu, Center for Genomic Medicine, Massachusetts General Hospital

Thursday, October 16, 2–2:15pm

Room 156ABC/Level 1
UW: Benchmarking long-read variant sensitivity across ONT and PacBio platforms using known clinically reported variants in a cohort of critically ill newborns
Poster #: TBD
Author: Colby Marvin, Univeristy of Washington
Resolution of the D4Z4 repeat responsible for facioscapulohumeral muscular dystrophy with HiFi sequencing
Poster #: TBD
Xiao Chen, PacBio
SeqFirst: The value of a “sequencing first” approach: qualitative interviews with SeqFirst families
Poster #: TBD
Olivia Sommerland, University of Washington
PCGC: Large-scale WES integrating research and clinical genetic testing cohorts identifies novel risk genes for congenital heart disease
Poster #: TBD
Wenxing Li, Columbia University Irving Medical Center
Machine Learning Approach Identifies Genes with Rare Variants Predisposing to Thoracic Aortic Aneurysms and Acute Aortic Dissections
Poster #: TBD
Dong-chuan Guo, University of Texas Health Science Center at Houston
Learn more about our latest updates & news
Read our blog